Raymond Hurst

At Arkuda, Raymond conducts studies in nonclinical model systems that establish a relationship between experimental compounds and their desired effects and side effects in order to provide future guidance on clinical development. He has more than 20 years of CNS drug discovery experience spanning small, mid and large-sized biopharmaceutical companies. Prior to joining Arkuda, he served as Director, Biology and Pharmacology at Concert Pharmaceuticals and held positions of increasing responsibility at Pharmacia, Pfizer, Amgen, FORUM Pharmaceuticals and Quartet Medicine. Throughout his career, Raymond has focused on establishing pharmacology relationships that bridge molecular and cellular pharmacology to animal physiology and behavior. He received his undergraduate degree in microbiology from Texas A&M University and a PhD in cell biology and anatomy from the Oregon Health & Science University. Raymond completed his postdoctoral training at UCLA in the Department of Anesthesiology and in the Neuropsychiatric Institute, where he investigated neuronal ion channel function and synaptic physiology both during development and in neurodegenerative disorders.